HOYA Corporation
7741.T · Tokyo Stock Exchange · JPY
23.525,00JPY
+340,00 (+1,47 %)Stand 10. Nov., 2:30
Kennzahlen
- Eröffnung
- 23.850,00
- Vortag
- 23.185,00
- Tagesspanne
- 23.415,00 – 23.860,00
- 52 Wochen
- 21.575,00 – 30.400,00
- Volumen
- 350.700
- Ø Volumen
- 1,21 Mio.
- Börsenwert
- 7,87 Bio. ¥
- KGV
- 28,0
- Gewinn je Aktie (TTM)
- 839,95
- Dividendenrendite
- 1,3 %
- Beta
- 1,1
- Nächste Zahlen
- –
Finanzen
| JPY | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Umsatz | 947,75 Mrd. | 866,03 Mrd. | 762,61 Mrd. | 723,58 Mrd. | 661,47 Mrd. |
| Herstellungskosten | 199,11 Mrd. | 172,45 Mrd. | 156,31 Mrd. | 156,53 Mrd. | 150,42 Mrd. |
| Bruttogewinn | 748,64 Mrd. | 693,58 Mrd. | 606,3 Mrd. | 567,05 Mrd. | 511,05 Mrd. |
| Forschung und Entwicklung | 0 | 35,28 Mrd. | 33 Mrd. | 29,42 Mrd. | 25,38 Mrd. |
| Vertrieb und Verwaltung | 468,22 Mrd. | 314,65 Mrd. | 276,64 Mrd. | 245,04 Mrd. | 213,04 Mrd. |
| Operatives Ergebnis | 280,43 Mrd. | 343,63 Mrd. | 296,64 Mrd. | 292,59 Mrd. | 272,62 Mrd. |
| EBITDA | 387,88 Mrd. | 309,48 Mrd. | 284,45 Mrd. | 266,2 Mrd. | 254,48 Mrd. |
| Nettogewinn | 253,08 Mrd. | 202,1 Mrd. | 181,38 Mrd. | 168,64 Mrd. | 164,51 Mrd. |
| Gewinn je Aktie (verwässert) | 743,82 | 581,26 | 515,27 | 469,47 | 445,93 |
Bewertung
Letzte 12 Monate
- KGV
- 28,0
- Kurs-Umsatz-Verhältnis
- 7,8
- Kurs-Buchwert-Verhältnis
- 7,8
- PEG
- 0,7
- Bruttomarge
- 78,5 %
- Operative Marge
- 31,1 %
- Nettomarge
- 28,0 %
- Verschuldungsgrad
- 0,0
- EV/EBITDA
- 17,5
- Eigenkapitalrendite
- 27,7 %
- Kapitalrendite (ROIC)
- 21,8 %
- Free-Cashflow-Rendite
- 3,1 %
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Quartalszahlen
Gerade nicht verfügbar.
Dividenden und Splits
Gerade nicht verfügbar.
Aktiensplits
Gerade nicht verfügbar.
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
Gerade nicht verfügbar.
Vergleichbare Unternehmen
Gerade nicht verfügbar.
Über das Unternehmen
Globally recognized as a med-tech innovator, HOYA Corporation is a prominent provider of advanced technology and healthcare solutions worldwide. Its comprehensive portfolio of life care products encompasses vision correction items such as eyeglasses and contact lenses, alongside sophisticated medical devices including endoscopes, intraocular lenses, and surgical instruments for laparoscopic procedures. HOYA also supplies automated endoscope cleaning systems and various medical essentials like prosthetic ceramic fillers and metallic implants. Complementing its medical offerings, the company operates Eyecity, a specialized retail chain for contact lenses. In the realm of information technology, HOYA manufactures crucial components such as mask blanks and photomasks for semiconductor and liquid crystal display fabrication, as well as glass disks for hard disk drives. Its imaging products segment includes optical glasses, specialized lenses, colored glass filters, and laser/UV light source equipment. Furthermore, the company extends its expertise into software and cloud services, offering ReadSpeaker, a speech synthesis application, and cloud platforms like Kinnosuke for time and attendance management, and Yonosuke for electronic payslip distribution. HOYA Corporation, established in 1941, is headquartered in Tokyo, Japan.
- CEO
- Eiichiro Ikeda
- Mitarbeitende
- 37.752
- Hauptsitz
- Tokyo, TY, JP
- Sektor
- Healthcare
- Branche
- Medical - Instruments & Supplies
- Börsengang
- 1. Jan. 2001
- Website
- hoya.com
Nachrichten
Gerade nicht verfügbar.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.